The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.
The genetic testing results also inform patients’ family members about their cancer risks so they can be proactive in screening and prevention. For now, GENETECA™ is only available to people with ...
A patient found to carry a BRCA1 pathogenic variant is not referred to a certified genetic counselor in her health system.
Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...
One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid ...
Neighbours star Viva Bianca has opened up about her breast cancer diagnosis after discovering she has the BRCA1 gene. The ...
While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common ...
OncoAssure Ltd, an Irish medical diagnostic company, announced the publication of new data in the journal BJUI Compass that ...
A new NHS genetic testing programme has identified hundreds of people with Jewish ancestry at increased risk of cancer ...
Steph Peacey, 28, was diagnosed with triple negative breast cancer in August last year after she noticed that her left breast ...
Sharni Marks, 31, was found to have a mutation in the BRCA2 gene back in 2018, which increases the risk of developing ovarian ...
“Genetic testing and targeted therapies are key components of this journey, offering hope and new possibilities for those affected by breast cancer.” “Outsmarting” breast cancer ...